212 related articles for article (PubMed ID: 28947138)
21. Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.
Connor AA; Denroche RE; Jang GH; Lemire M; Zhang A; Chan-Seng-Yue M; Wilson G; Grant RC; Merico D; Lungu I; Bartlett JMS; Chadwick D; Liang SB; Eagles J; Mbabaali F; Miller JK; Krzyzanowski P; Armstrong H; Luo X; Jorgensen LGT; Romero JM; Bavi P; Fischer SE; Serra S; Hafezi-Bakhtiari S; Caglar D; Roehrl MHA; Cleary S; Hollingsworth MA; Petersen GM; Thayer S; Law CHL; Nanji S; Golan T; Smith AL; Borgida A; Dodd A; Hedley D; Wouters BG; O'Kane GM; Wilson JM; Zogopoulos G; Notta F; Knox JJ; Gallinger S
Cancer Cell; 2019 Feb; 35(2):267-282.e7. PubMed ID: 30686769
[TBL] [Abstract][Full Text] [Related]
22. Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples.
Bournet B; Pointreau A; Souque A; Oumouhou N; Muscari F; Lepage B; Senesse P; Barthet M; Lesavre N; Hammel P; Levy P; Ruszniewski P; Cordelier P; Buscail L
Pancreatology; 2012; 12(1):27-34. PubMed ID: 22487470
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound-guided fine needle aspiration.
Hosoda W; Takagi T; Mizuno N; Shimizu Y; Sano T; Yamao K; Yatabe Y
Pathol Int; 2010 May; 60(5):358-64. PubMed ID: 20518885
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic biomarkers: could they be the answer?
Lamarca A; Feliu J
World J Gastroenterol; 2014 Jun; 20(24):7819-29. PubMed ID: 24976720
[TBL] [Abstract][Full Text] [Related]
25. Precision medicine in pancreatic cancer: treating every patient as an exception.
Herbst B; Zheng L
Lancet Gastroenterol Hepatol; 2019 Oct; 4(10):805-810. PubMed ID: 31511204
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
Ciernikova S; Earl J; García Bermejo ML; Stevurkova V; Carrato A; Smolkova B
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521716
[TBL] [Abstract][Full Text] [Related]
27. Update on the management of pancreatic cancer: surgery is not enough.
Ansari D; Gustafsson A; Andersson R
World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
[TBL] [Abstract][Full Text] [Related]
28. Patient-Derived Organoid Pharmacotyping Guides Precision Medicine for Pancreatic Cancer.
Zhang Y; Houchen CW; Li M
Clin Cancer Res; 2022 Aug; 28(15):3176-3178. PubMed ID: 35617521
[TBL] [Abstract][Full Text] [Related]
29. Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches.
Sahin IH; Lowery MA; Stadler ZK; Salo-Mullen E; Iacobuzio-Donahue CA; Kelsen DP; O'Reilly EM
Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):893-905. PubMed ID: 26881472
[TBL] [Abstract][Full Text] [Related]
30. A mechanopharmacology approach to overcome chemoresistance in pancreatic cancer.
Coppola S; Carnevale I; Danen EHJ; Peters GJ; Schmidt T; Assaraf YG; Giovannetti E
Drug Resist Updat; 2017 Mar; 31():43-51. PubMed ID: 28867243
[TBL] [Abstract][Full Text] [Related]
31. A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor.
Gayet O; Loncle C; Duconseil P; Gilabert M; Lopez MB; Moutardier V; Turrini O; Calvo E; Ewald J; Giovannini M; Gasmi M; Bories E; Barthet M; Ouaissi M; Goncalves A; Poizat F; Raoul JL; Secq V; Garcia S; Viens P; Dusetti N; Iovanna J
Oncotarget; 2015 Jan; 6(2):746-54. PubMed ID: 25481873
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenetics of treatments for pancreatic cancer.
El Hassouni B; Li Petri G; Liu DSK; Cascioferro S; Parrino B; Hassan W; Diana P; Ali A; Frampton AE; Giovannetti E
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):437-447. PubMed ID: 31100206
[No Abstract] [Full Text] [Related]
33. Toward stratification of patients with pancreatic cancer: Past lessons from traditional approaches and future applications with physical biomarkers.
Koay EJ; Amer AM; Baio FE; Ondari AO; Fleming JB
Cancer Lett; 2016 Oct; 381(1):237-43. PubMed ID: 26806807
[TBL] [Abstract][Full Text] [Related]
34. Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts.
Kruger S; Haas M; Ormanns S; Bächmann S; Siveke JT; Kirchner T; Heinemann V; Boeck S
World J Gastroenterol; 2014 Aug; 20(31):10769-77. PubMed ID: 25152580
[TBL] [Abstract][Full Text] [Related]
35. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.
Giulietti M; Occhipinti G; Principato G; Piva F
Cell Oncol (Dordr); 2016 Aug; 39(4):379-88. PubMed ID: 27240826
[TBL] [Abstract][Full Text] [Related]
36. Metabolism addiction in pancreatic cancer.
Blum R; Kloog Y
Cell Death Dis; 2014 Feb; 5(2):e1065. PubMed ID: 24556680
[TBL] [Abstract][Full Text] [Related]
37. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with a KRAS mutation assay using allelic discrimination improves the diagnosis of pancreatic cancer.
Bournet B; Selves J; Grand D; Danjoux M; Hanoun N; Cordelier P; Buscail L
J Clin Gastroenterol; 2015 Jan; 49(1):50-6. PubMed ID: 24798941
[TBL] [Abstract][Full Text] [Related]
38. Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration.
Krishna SG; Bhattacharya A; Ross WA; Ladha H; Porter K; Bhutani MS; Lee JH
J Gastroenterol Hepatol; 2015 Oct; 30(10):1552-60. PubMed ID: 25867963
[TBL] [Abstract][Full Text] [Related]
39. Lipocalin-2 Expression in Pancreas Adenocarcinoma Tumor Microenvironment Via Endoscopic Ultrasound Fine Needle Biopsy Is Feasible and May Reveal a Therapeutic Target.
Gleeson FC; Levy MJ; Jackson RA; Murphy SJ; Halling KC; Kipp BR; Graham RP; Zhang L
Pancreas; 2020; 49(10):e98-e99. PubMed ID: 33122534
[No Abstract] [Full Text] [Related]
40. KRAS mutation analysis of washing fluid from endoscopic ultrasound-guided fine needle aspiration improves cytologic diagnosis of pancreatic ductal adenocarcinoma.
Park JK; Lee YJ; Lee JK; Lee KT; Choi YL; Lee KH
Oncotarget; 2017 Jan; 8(2):3519-3527. PubMed ID: 27974679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
